Skip to content

TB INFI SOINS

Active
Private limited companyfounded 2024active for 2 yearsRue du Delta (C.) 19, 7000 Mons, BelgiumKBO/BCE: BE 1010.635.476
Summary

TB INFI SOINS has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €155,565 and a net result of €154,065. Its solvency ranks better than 65% of 19,737 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 1.2% (low).

Overview

Activity
Nursing and midwifery
NACE 86940
1 site
Size
€197,154total assets 2024
Equity
€155,565
Profit
€154,065
Turnover not published (micro format)
Financial health
56 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
1.2%
Structure
Accounts filed 126 days late
Why 56raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 04-12-2025)1 financial year not filed after the legal deadline; latest accounts 126 days late; 1 of the last 3 lateFounded in 2024lowers riskSector: Human health activities (NACE 86)Show the evidence

Checked score

Score 2024
56 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 59% of its sector peers (NACE 86, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength
Strong
Solvency 100
equity 78.9% of total assets
Liquidity 46
short-term debt 20.8% · cash 2.5%
Profitability 100
return on assets 78.1%
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,085 companies, NACE 86, micro)
Last 24 months 07-2025: 0.3% 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.2%▼ -0.1 percentage points vs 12-2025lowest value 02-2026: 0.3%▲ +0.1 percentage points vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.5%▲ +0.2 percentage points vs 07-2026 09-2026: 0.7%▲ +0.2 percentage points vs 08-2026 10-2026: 1.2%▲ +0.5 percentage points vs 09-2026highest value
Credit of up to €8,000 on 30-day terms, only on tighter conditions: the latest accounts were filed more than 90 days after the deadline
Liquidity ample (current ratio 4.81, above the usual 1.5; short-term debt: 20.8% and cash: 2.5% of total assets), and 21.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 14% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 18-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Figures for financial year 2024 (filed 04-12-2025)
NBB · annual accounts
raises risk · 1 financial year not filed after the legal deadline; latest accounts 126 days late; 1 of the last 3 late
NBB · filings
raises risk · Founded in 2024
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-12-2025, 126 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 1 filing
Deviation from the deadline
2024
126 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its 2024 accounts 126 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2024 · micro…
  2. IncorporationFounder · Founding capital ·…

Key points

  • Caution: Latest accounts filed lateafter the legal deadline 126 days View
  • Positive: Among the best 18% on net resultsector median €58,802 · 19,727 companies €154,065 View
  • Total assets 2024first financial year filed €197,154 View

By topic

Financials

Financial year
2024
Total assets
€197,154
Profit
€154,065
Solvency
78.9%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Nursing and midwiferyNACE 86940
Founded
21-06-2024
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Articles of association

Provisions read
31
Annual meeting
Second Saturday of June at 18:00
Purpose
“La pratique de l'art infirmier,le nursing,les soins infirmiers tant au siège social qu'à…” (deed in French)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.